This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
ORIGINAL RESEARCH PAPER
Reischig, T. et al. Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. J. Am. Soc. Nephrol. doi:10.1681/ASN.2012010100
Rights and permissions
About this article
Cite this article
Kelsey, R. Pre-emptive CMV therapy versus universal CMV prophylaxis in renal transplant recipients. Nat Rev Nephrol 8, 614 (2012). https://doi.org/10.1038/nrneph.2012.210
Published:
Issue date:
DOI: https://doi.org/10.1038/nrneph.2012.210